Myeloma
Costs High for Myeloma Patients Not Getting Low-Income Subsidy
May 31, 2017For those aged 75 to 84 years, LIS receipt linked to increased odds of receiving immunomodulatory drugs
Genetic test helps identify risk for more aggressive disease, improving myeloma treatment
September 02, 2015New research has identified as few as nine genetic features would need to be tested to identify high-risk patients who might benefit from intensive myeloma treatment.
ASCO: Elotuzumab demonstrates benefit in multiple myeloma
June 05, 2015Survival gains observed when elotuzumab was added to treatment.
ASH: Carfilzomib increases survival in relapsed multiple myeloma
December 12, 2014Improved progression-free survival in relapsed multiple myeloma has been seen with the addition of carfilzomib to lenalidomide and dexamethasone therapy.
New potential therapeutic agents for myeloma are on the horizon
December 10, 2014Recent therapeutic progress has improved outcomes for patients with myeloma; however, the complex biology of this disease continues to challenge treatment.
New myeloma treatment options promising
September 10, 2014New multiple myeloma treatment options have shown promise for patients aged 65 years and younger and for newly diagnosed individuals ineligible for stem-cell transplantation, according to two studies.
Treatment effective for smoldering multiple myeloma
August 01, 2013Lenalidomide plus dexamethasone delays progression, improves survival versus observation
Kyprolis approved for multiple myeloma
July 26, 2012Carfilzomib is approved for people who have been treated with at least two other therapies.
Bortezomib ups response, survival in multiple myeloma
July 25, 2012Bortezomib induction/maintenance up complete response, progression-free, and overall survival rates.
Coping with Multiple Myeloma
July 18, 2012These tips can help patients with multiple myeloma learn more about how to cope with the disease.
Lenalidomide maintenance beneficial in multiple myeloma
May 11, 2012Three studies show benefit of lenalidomide, including after induction therapy or stem-cell transplant.
Blood cancers often require termination of early pregnancy
February 29, 2012The urgent need for treatment may require a woman with a hematologic cancer to end an early-stage pregnancy, but not necessarily a later-stage one.
Multiple Myeloma: Finding Resources and Support
February 21, 2012This fact sheet reviews a number of resources available to patients coping with multiple myeloma, from the health care team to in the community.
Using ESAs in patients with cancer-related anemia
February 15, 2012Although the risks of erythropoietin-stimulating agents can outweigh the benefits, select patients may benefit.
Multiple Myeloma: Making the Most of Your Medical Appointments
December 19, 2011Many people see their cancer care as a collaboration. This fact sheet provides tips for patients with multiple myeloma for improving communication with providers during office visits.
Overall cancer mortality rates decrease, but incidence of some cancers increases
April 08, 2011Overall, cancer incidence rates fell approximately 1% annually and overall death rates decreased by an average of 1.6% annually between 2003 and 2007.
Sign Up for Free e-newsletters
ONA Articles
- Study Finds Association Between Folate Intake and Risk of Cutaneous Melanoma
- Qualitative Analysis of Myeloma Patients' Experience Following Hematopoietic Stem Cell Transplant
- Melanoma Outcomes Improved With Nivolumab Alone or Plus Ipilimumab
- Involved-Field Radiotherapy Plus Chemotherapy Prolonged PFS in Follicular Lymphoma
- Patient Fears of Placebo Use in Clinical Trials
- Implementing an Ambulatory Adherence Program May Improve Oral Anticancer Medications Compliance
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- Managing Dyspnea With Fentanyl in Patients With Cancer at End of Life
- Two Programs, One Goal: Meeting the Challenges of Oncology Navigation
- Navigating Patients with Hematologic Malignancies
- Study Finds Association Between Folate Intake and Risk of Cutaneous Melanoma
- Oral Contraceptive Use May Not Be Associated With Increased Melanoma Risk
- Melanoma Outcomes Improved With Nivolumab Alone or Plus Ipilimumab
- Staff Education Leads to Increase in Oncology Rehabilitation Referrals
- Certain Risk Factors May Decrease Overall Survival in Pediatric B-NHL
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |